Skip to content

Treatment Of melasma with Unani drug

Therapeutic evaluation of topical Tukhm-i Turb (Raphanus sativus) in Kalaf (melasma) - a randomised control trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044080
Enrollment
40
Registered
2022-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Tukhm-i Turb with Asl: Tukhm-i Turb with Asl (honey) in the form of Tila will be used topically in quantity sufficient twice daily for 8 weeks. Control Intervention1: Hydroquinone 4%: H

Sponsors

Luqman Unani Medical College Hospital and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of bilateral facial Kalaf Epidermal and mixed melasma

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients with history or presence of any skin allergy or allergy to hydroquinone Patients with history or presence of any serious disease including immunological conditions like HIV current malignancies diabetes mellitus Hypertension etc Patients who had used within 15 days prior to baseline any topical and systemic treatment for scalp diseases Patient with history of chemical peels and facial laser treatment within 9 months and use of sun protector creams

Design outcomes

Secondary

MeasureTime frame
Change in Patient Global Assessment (PtGA) for melasma severity on 100mm VAS Change in Dermatology life quality index (DLQI)Timepoint: before and after treatment

Primary

MeasureTime frame
Change in modified Melasma Area and Severity Index (mMASI)Timepoint: baseline to end of treatment

Countries

India

Contacts

Public ContactNazim Husain

Luqman Unani Medical College Hospital and Research Centre

drdafedar1@gmail.com9032786832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026